Meeting
2019 ASCO Annual Meeting
An open label phase I/IIa study to evaluate the safety and efficacy of CCS1477 as monotherapy and in combination in patients with advanced solid/metastatic tumors.
Authors
Johann S. De Bono
Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, United Kingdom
Johann S. De Bono , Elena Cojocaru , Elizabeth Ruth Plummer , Tomasz Knurowski , Karen Clegg , Fay Ashby , Neil Pegg , William West , Anthony Nigel Brooks
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer - Advanced Disease
Clinical Trial Registration Number
NCT03568656
Citation
J Clin Oncol 37, 2019 (suppl; abstr TPS5089)
DOI
10.1200/JCO.2019.37.15_suppl.TPS5089
Abstract #
TPS5089
Poster Bd #
199b
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
CYCLONE 2: A phase II, randomized, placebo-controlled study of abiraterone acetate plus prednisone with or without abemaciclib in patients with metastatic castration-resistant prostate cancer.
First Author: Matthew Raymond Smith
Poster
2017 Genitourinary Cancers Symposium
Clinical activity and safety of ASN001, a selective CYP17 lyase inhibitor, administered without prednisone in men with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Jorge A. Garcia
Poster
2023 ASCO Annual Meeting
Phase I trial of enzalutamide (Enz) plus the glucocorticoid receptor antagonist relacorilant (Rela) for patients with metastatic castration resistant prostate cancer.
First Author: Kunal Desai
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase 2 expansion study of ARV-766, a PROTAC androgen receptor (AR) degrader, in metastatic castration-resistant prostate cancer (mCRPC).
First Author: Daniel P. Petrylak